About the Authors and This Research

This study was co-authored by three leading figures in clinical laboratory science. James C. Boyd holds an h-index of 31 with 3,891 cumulative citations, making him one of the most influential voices in quantitative diagnostic methodology and clinical decision error analysis. Lorin M. Bachmann and David E. Bruns are both recognized contributors to clinical chemistry standardization research, with their work regularly cited by the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). Published in 2017, the paper has since accumulated 50 citations, including 3 high-impact citations—a testament to its enduring relevance in the ongoing global debate on measurement standardization.

The research addressed a deceptively simple question: among the 24 serum albumin measurement procedures in widespread clinical use worldwide, how many actually produce consistent, trustworthy results? The researchers collected samples from patients with and without renal disease, used ERM-DA470k/IFCC reference material as a gold standard, and systematically evaluated three categories of measurement methods: 3 immunochemical methods, 9 bromocresol green (BCG) methods, and 12 bromocresol purple (BCP) methods.

Core Findings: Systematic Bias Across 24 Measurement Procedures

The findings exposed a measurement landscape far more fragmented than clinical guidelines had assumed—and the biases were systematic rather than random, pointing to fundamental methodological architecture problems rather than isolated operational errors.

Finding One: BCG Methods Show the Widest Bias, Especially at Low Concentrations

Among the 9 BCG methods, only 5 recovered the reference material value within its uncertainty. The remaining 4 showed significant bias. Mean biases for BCG methods relative to the Tina-quant immunochemical reference procedure ranged from 1.5% to 13.9%, with biases becoming more pronounced at lower albumin concentrations. This is clinically critical: patients with kidney failure—precisely those requiring the most accurate measurements—tend to have lower albumin levels, meaning BCG methods systematically overestimate albumin in the population where accurate measurement matters most.

Finding Two: BCP Methods Perform Better But Remain Imperfect

Of the 12 BCP methods, 10 recovered the reference material value within acceptable uncertainty. Mean biases ranged from -5.4% to 1.2%, and crucially, these biases did not amplify at lower albumin concentrations—a significant advantage over BCG methods. However, biases for plasma samples were consistently higher than for serum samples across all method types, introducing an additional layer of measurement uncertainty tied to sample matrix rather than measurement chemistry alone. The study ultimately designated the Tina-quant immunochemical method as the reference measurement procedure and concluded that all clinical guidelines and calculations must specify the albumin measurement method used until full harmonization is achieved.

Implications for Taiwan Business Continuity Management (BCM) Practice

The methodological lesson of this study extends far beyond clinical chemistry. For Taiwan enterprises pursuing ISO 22301 certification and building robust BCM frameworks, the core parallel is this: when the measurement tools underlying critical decisions carry unacknowledged systematic biases, the sophistication of the decision framework is irrelevant. The conclusions will be structurally compromised.

In BCM practice, this manifests as a measurement consistency problem that most Taiwan organizations have not explicitly addressed. Three dimensions deserve immediate attention:

First, RTO and RPO targets must be grounded in standardized impact quantification methods. Many Taiwan enterprises set RTO and RPO targets using heterogeneous measurement approaches across departments—some using revenue loss as the baseline, others using service unavailability hours, others using customer complaint volumes. This mirrors the study's scenario of 24 measurement procedures producing incompatible results. Without a unified quantification standard embedded in the BCM architecture, cross-departmental RTO and RPO comparisons and prioritization decisions lack a reliable foundation.

Second, BIA methodological consistency is an implicit requirement of ISO 22301. ISO 22301 Clause 8.2.2 requires organizations to conduct Business Impact Analysis but does not mandate a specific quantification method. In practice, this methodological neutrality often becomes methodological anarchy, with each department developing its own approach. Taiwan enterprises should establish a standardized BIA methodology that functions as an organizational reference procedure—analogous to the study's Tina-quant reference method—while documenting any departmental variations and applying systematic bias corrections.

Third, the introduction of management algorithms into BCM decision-making requires rigorous methodological discipline. As Taiwan enterprises increasingly deploy AI-based tools for risk assessment and BCP trigger conditions, the principles of unbiased algorithms become operationally critical. If the training data for these systems derives from historically inconsistent measurement frameworks, the algorithms will inherit and amplify the systematic biases embedded in that data—exactly paralleling the study's finding that BCG method biases expand at lower albumin concentrations.

How Winners Consulting Services Co. Ltd. Helps Taiwan Enterprises

積穗科研股份有限公司（Winners Consulting Services Co. Ltd.）assists Taiwan enterprises in building BCP Business Continuity Plans aligned with ISO 22301, establishing RTO/RPO targets, conducting Business Impact Analysis (BIA), and executing crisis management exercises. To address the measurement consistency challenge this study illuminates, we recommend three concrete actions:

1. Establish an organization-wide standardized BIA impact quantification framework: Working from the study's logic of designating a reference measurement procedure, Winners Consulting helps enterprises develop a unified impact scoring system covering financial loss, service disruption duration, regulatory compliance risk, and reputational impact—with explicit measurement definitions and data sources for each dimension, ensuring cross-departmental BIA results are genuinely comparable.
2. Introduce bias correction mechanisms into RTO/RPO setting processes: For different business process types (production lines, IT systems, customer service operations), establish correction factors that reflect systematic differences between measurement approaches used in different contexts. This should be embedded as a fixed agenda item in ISO 22301 annual management reviews to ensure target accuracy improves continuously over time.
3. Adopt mandatory method annotation conventions in all BCM documentation: Drawing directly from the study's conclusion that clinical guidelines must specify the albumin measurement method used, Winners Consulting guides enterprises to document the specific impact assessment methodology, data sources, and assessment date in all BCP documents—ensuring complete audit trails and full compliance with ISO 22301 Clause 7.5 on documented information.

Frequently Asked Questions

How does methodological inconsistency in BIA actually affect RTO prioritization decisions?

When different departments quantify business impact using different metrics—revenue loss versus downtime hours versus customer complaints—the resulting RTO values are structurally incomparable, even if each department's internal calculations are internally consistent. This mirrors the study's finding that BCG and BCP methods, though each internally valid, produced mean biases ranging from -5.4% to 13.9% relative to the reference procedure. In BCM practice, this means RTO prioritization decisions made by senior management based on aggregated BIA data may systematically favor departments that used more conservative measurement methods, not departments with genuinely higher business criticality. The solution is establishing a unified BIA quantification standard under ISO 22301 Clause 8.2.2 before collecting impact data across the organization.

What are the most common ISO 22301 compliance gaps for Taiwan enterprises?

Based on Winners Consulting's implementation experience, the three most frequent compliance gaps for Taiwan enterprises are: first, incomplete documented information under ISO 22301 Clause 7.5, particularly inconsistent version control across BCP documents; second, BIA processes under Clause 8.2.2 that rely on qualitative descriptions rather than quantitative baselines, making results non-auditable; and third, internal audit programs under Clause 9.2 that are either infrequent or insufficiently deep to identify mechanism degradation between certification cycles. These three gaps are consistently identified by certification auditors and are also the areas most likely to cause post-certification mechanism failure. A structured gap analysis before initiating the certification process can reduce total preparation time by 20% to 30%.

What are the concrete steps and timeline for ISO 22301 certification?

A typical ISO 22301 implementation runs 7 to 12 months depending on organizational size and existing mechanism maturity. Phase One (Months 1-2): Current state assessment and gap analysis against ISO 22301 requirements. Phase Two (Months 3-5): Framework design, including BIA methodology standardization, RTO/RPO target setting, and BCP documentation development. Phase Three (Months 6-9): Mechanism implementation, staff training, tabletop exercises, and live drills. Phase Four (Months 10-12): Internal audit, management review, and external certification application. Winners Consulting adjusts the emphasis of each phase based on available organizational resources, ensuring the implementation produces a genuinely operational BCM system rather than documentation assembled for audit compliance alone.

What resources does ISO 22301 certification require, and how should expected benefits be evaluated?

Resource requirements vary significantly by organizational scale. For mid-sized Taiwan enterprises (200 to 500 employees), the typical investment involves a core internal team of 3 to 5 people committing approximately 40 to 80 combined hours per month over 7 to 12 months, plus external consulting fees. On the benefit side, organizations with mature BCM mechanisms demonstrate average post-incident recovery time reductions of 40% to 60% compared to unstructured responses. Equally importantly, ISO 22301 certification has become an explicit vendor qualification requirement for an increasing number of multinational clients in the financial services, healthcare, and technology sectors. For Taiwan enterprises serving these supply chains, the commercial access value of certification typically justifies the investment within 2 to 3 years.

Why should Taiwan enterprises choose Winners Consulting for BCM and ISO 22301 implementation?

Winners Consulting Services Co. Ltd. (積穗科研股份有限公司) brings deep expertise in translating ISO 22301's international framework requirements into operationally sound BCM systems calibrated to Taiwan's regulatory environment, industrial structure, and organizational culture. Our cross-industry experience spans manufacturing, financial services, technology, and healthcare sectors, giving us a nuanced understanding of sector-specific risk profiles and supply chain dependencies. We provide end-to-end support from gap analysis and BIA methodology design through RTO/RPO target setting and certification application—with explicit attention to the measurement consistency principles this study highlights. Our complimentary initial diagnostic gives enterprises a clear picture of their current readiness before committing to full implementation, reducing the risk of resource misallocation.

測定の調和性とBCM業務継続管理への示唆：積穗科研の視点

積穗科研股份有限公司（Winners Consulting Services Co. Ltd.）は、台湾の業務継続管理（BCM）専門機関として、2017年に発表された臨床化学分野の重要な研究から、ISO 22301に基づくBCP業務継続計画の構築に直結する方法論的洞察を導き出した。24種類の血清アルブミン測定手順を比較したこの研究は、同一指標が異なる方法で測定された場合、最大13.9%の系統的偏差が生じることを実証した。この発見は、BIA業務影響分析における測定の一致性がRTO復旧時間目標およびRPO復旧時点目標の信頼性を根本的に左右するという、台湾企業が見落としがちなBCM上の脆弱性と直接対応している。